Evidence map›Paper›PMID 27525435›Full record

ArticleThe Journal of clinical investigation2016

Urea impairs β cell glycolysis and insulin secretion in chronic kidney disease.

Laetitia Koppe, Elsa Nyam, Kevin Vivot, Jocelyn E Manning Fox, Xiao-Qing Dai, Bich N Nguyen, Dominique Trudel, Camille Attané, Valentine S Moullé, Patrick E MacDonald and 2 more

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of clinical investigation, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 84 papers.

0numbers the graph read from it
0cells of the map it votes in
84citing papers in PubMed
7.8field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

84 citing papers in PubMed, 161 citations in OpenAlex.

  1. Gut microbes · 2026
    Trial
  2. Article
  3. Article
  4. Observational
  5. Review
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Review

24 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

12 authors at 3 institutions in 1 country.

Laetitia Koppe
Elsa Nyam
Kevin Vivot
Jocelyn E Manning Fox
Xiao-Qing Dai
Bich N Nguyen
Dominique Trudel
Camille Attané
Valentine S Moullé
Patrick E MacDonald
Julien Ghislain
Vincent Poitout
Centre Hospitalier de l’Université de Montréal · CAUniversité de Montréal · CAUniversity of Alberta · CA

Funding

Neutral lipid dysregulation of the pancreatic beta-cellR01DK058096 · NIDDK · UNIVERSITY OF MONTREAL HOSPITAL · PI POITOUT, VINCENT · 2001 to 2020
$3.9M
Canadian Institutes of Health Research MOP 77686NIDDK NIH HHS R01 DK058096
6 · The paper itself

Abstract

Disorders of glucose homeostasis are common in chronic kidney disease (CKD) and are associated with increased mortality, but the mechanisms of impaired insulin secretion in this disease remain unclear. Here, we tested the hypothesis that defective insulin secretion in CKD is caused by a direct effect of urea on pancreatic β cells. In a murine model in which CKD is induced by 5/6 nephrectomy (CKD mice), we observed defects in glucose-stimulated insulin secretion in vivo and in isolated islets. Similarly, insulin secretion was impaired in normal mouse and human islets that were cultured with disease-relevant concentrations of urea and in islets from normal mice treated orally with urea for 3 weeks. In CKD mouse islets as well as urea-exposed normal islets, we observed an increase in oxidative stress and protein O-GlcNAcylation. Protein O-GlcNAcylation was also observed in pancreatic sections from CKD patients. Impairment of insulin secretion in both CKD mouse and urea-exposed islets was associated with reduced glucose utilization and activity of phosphofructokinase 1 (PFK-1), which could be reversed by inhibiting O-GlcNAcylation. Inhibition of O-GlcNAcylation also restored insulin secretion in both mouse models. These results suggest that insulin secretory defects associated with CKD arise from elevated circulating levels of urea that increase islet protein O-GlcNAcylation and impair glycolysis.

Indexed as

GlycolysisAnimalsAntioxidantsCyanatesDisease Models, AnimalExocytosisGlucokinaseGlucoseGlucose Tolerance TestInsulinInsulin-Secreting CellsInsulin SecretionIslets of LangerhansKidney Failure, ChronicMaleMiceAntioxidantsCyanatesGlucokinaseGlucoseInsulinPhosphofructokinase-1Reactive Oxygen SpeciesUrea

Identifiers

PMID27525435
PMCPMC5004963
OpenAlexW2514558945

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.